Breast cancer research program (bcrp) support services, congressionally directed medical research programs (cdmrp)

Ended Awarded Last action

Contract number
HT942524F0050
Awardee
Awarding agency
Obligated
$664,625

Award facts

Opportunity
Contract value 87% obligated
$760,375.09 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00005 · Support services breast cancer research program for congressionally directed medical research programs -$95,750
Funding Only Action P00004 · Breast cancer research program support services, congressionally directed medical research programs $171,031
Supplemental Agreement for work within scope P00003 · Support services for the congressionally directed medical research programs, breast cancer research program -$20,157
Funding Only Action P00002 $100,000
Supplemental Agreement for work within scope P00001 · Support services for the breast cancer research program, congressionally directed medical research programs $0
Original award $509,501

About this award

This is a delivery order contract awarded by the Defense Health Agency (DHA) to Leidos, Inc. under the Breast Cancer Research Program (BCRP) of the Congressionally Directed Medical Research Programs (CDMRP). The contract has a total potential value of $760,375.09 and a period of performance through February 11, 2025. The contract provides BCRP support services and was not set aside for any specific business categories. Leidos, Inc. is the prime contractor, and the contract supports critical medical research programs within the DHA. The CDMRP is a funding program managed by the U.S. Department of Defense that supports peer-reviewed biomedical research.

Quick answers

Who was awarded contract HT942524F0050?

HT942524F0050 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on February 23, 2024.

How much is contract HT942524F0050 worth?

The government has obligated $664,625 on HT942524F0050. Its current value, with exercised options, is $760,375.

Is contract HT942524F0050 an order under another contract?

Yes. HT942524F0050 is a delivery order under HT942523D0002, an indefinite delivery contract.

Was contract HT942524F0050 competed?

The extent of competition for HT942524F0050 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award